[Granulosa cell carcinoma in pregnancy and cytostatic therapy in early post-partum period].
D000328:Adult; D000380:Agranulocytosis / Q000209:etiology; D000667:Ampicillin / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects*; D005260:Female; D006106:Granulosa Cell Tumor / Q000601:surgery*; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects*; D008413:Mastitis / Q000209:etiology; D009362:Neoplasm Metastasis / Q000517:prevention & control; D010051:Ovarian Neoplasms / Q000601:surgery*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000601:surgery*; D011644:Puerperal Disorders / Q000188:drug therapy*; D011645:Puerperal Infection / Q000188:drug therapy / Q000209:etiology*; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology
D000667:Ampicillin; D003520:Cyclophosphamide
Granulosazellkarzinom in der Schwangershaft und Zytostakatherapie im Frühwochenbett.